Literature DB >> 21252775

ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation.

.   

Abstract

A single course of corticosteroids is recommended for pregnant women between 24 weeks and 34 weeks of gestation who are at risk of preterm delivery within 7 days. A single course of antenatal corticosteroids should be administered to women with premature rupture of membranes before 32 weeks of gestation to reduce the risks of respiratory distress syndrome, perinatal mortality, and other morbidities. The efficacy of corticosteroid use at 32–33 completed weeks of gestation for preterm premature rupture of membranes is unclear, but treatment may be beneficial, particularly if pulmonary immaturity is documented. Sparse data exist on the efficacy of corticosteroid use before fetal age of viability, and such use is not recommended. A single rescue course of antenatal corticosteroids may be considered if the antecedent treatment was given more than 2 weeks prior, the gestational age is less than 32 6/7 weeks, and the women are judged by the clinician to be likely to give birth within the next week. However, regularly scheduled repeat courses or multiple courses (more than two) are not recommended. Further research regarding the risks and benefits, optimal dose, and timing of a single rescue course of steroid treatment is needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252775     DOI: 10.1097/AOG.0b013e31820eee00

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  29 in total

1.  Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.

Authors:  Waldemar A Carlo; Scott A McDonald; Avroy A Fanaroff; Betty R Vohr; Barbara J Stoll; Richard A Ehrenkranz; William W Andrews; Dennis Wallace; Abhik Das; Edward F Bell; Michele C Walsh; Abbot R Laptook; Seetha Shankaran; Brenda B Poindexter; Ellen C Hale; Nancy S Newman; Alexis S Davis; Kurt Schibler; Kathleen A Kennedy; Pablo J Sánchez; Krisa P Van Meurs; Ronald N Goldberg; Kristi L Watterberg; Roger G Faix; Ivan D Frantz; Rosemary D Higgins
Journal:  JAMA       Date:  2011-12-07       Impact factor: 56.272

2.  Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.

Authors:  M N Edelmann; C A Sandman; L M Glynn; D A Wing; E P Davis
Journal:  Psychoneuroendocrinology       Date:  2016-06-23       Impact factor: 4.905

3.  The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes.

Authors:  Seung Mi Lee; Roberto Romero; Jeong Woo Park; Sun Min Kim; Chan-Wook Park; Steven J Korzeniewski; Tinnakorn Chaiworapongsa; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-25

Review 4.  Acute Kidney Injury in Pregnancy.

Authors:  Belinda Jim; Vesna D Garovic
Journal:  Semin Nephrol       Date:  2017-07       Impact factor: 5.299

5.  Prevention and early recognition of necrotizing enterocolitis: a tale of 2 tools--eNEC and GutCheckNEC.

Authors:  Sheila M Gephart; Christine Wetzel; Brittany Krisman
Journal:  Adv Neonatal Care       Date:  2014-06       Impact factor: 1.968

Review 6.  Vermont Oxford Network: a worldwide learning community.

Authors:  Erika M Edwards; Danielle E Y Ehret; Roger F Soll; Jeffrey D Horbar
Journal:  Transl Pediatr       Date:  2019-07

Review 7.  Antenatal corticosteroids in the management of preterm birth: are we back where we started?

Authors:  Clarissa Bonanno; Ronald J Wapner
Journal:  Obstet Gynecol Clin North Am       Date:  2012-03       Impact factor: 2.844

8.  Glucocorticoids enhance CD163 expression in placental Hofbauer cells.

Authors:  Zhonghua Tang; Tracy Niven-Fairchild; Serkalem Tadesse; Errol R Norwitz; Catalin S Buhimschi; Irina A Buhimschi; Seth Guller
Journal:  Endocrinology       Date:  2012-11-09       Impact factor: 4.736

9.  Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.

Authors:  Melanie E Peffer; Uma R Chandran; Soumya Luthra; Daniela Volonte; Ferruccio Galbiati; Michael J Garabedian; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

10.  Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.

Authors:  Amanda L Horton; Yinglei Lai; Dwight J Rouse; Catherine Y Spong; Kenneth J Leveno; Michael W Varner; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Mary J O'Sullivan; Gary D V Hankins; Steve N Caritis
Journal:  Am J Perinatol       Date:  2014-09-21       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.